Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis
about
Management of HBV Infection in Liver Transplantation PatientsGeneration of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesHepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysisCurrent therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
P2860
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lamivudine therapy in patients ...... s with very low dose hepatitis
@en
Lamivudine therapy in patients ...... s with very low dose hepatitis
@nl
type
label
Lamivudine therapy in patients ...... s with very low dose hepatitis
@en
Lamivudine therapy in patients ...... s with very low dose hepatitis
@nl
prefLabel
Lamivudine therapy in patients ...... s with very low dose hepatitis
@en
Lamivudine therapy in patients ...... s with very low dose hepatitis
@nl
P2093
P356
P1476
Lamivudine therapy in patients ...... se hepatitis B immune globulin
@en
P2093
A Bartholomeusz
G W McCaughan
S A Locarnini
P304
P356
10.1002/LT.500050601
P407
P50
P577
1999-11-01T00:00:00Z